PEAK6’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47.8M Buy
1,119,300
+1,053,100
+1,591% +$57.2M 0.1% 175
2026
Q1
$4.15M Buy
66,200
+24,300
+58% +$1.94M 0.01% 992
2025
Q4
$4M Sell
41,900
-5,100
-11% -$500K 0.01% 1056
2025
Q3
$4.59M Buy
47,000
+3,500
+8% +$362K 0.01% 1070
2025
Q2
$4.67M Sell
43,500
-56,700
-57% -$5.74M 0.01% 1001
2025
Q1
$10.1M Buy
100,200
+34,100
+52% +$3.43M 0.02% 601
2024
Q4
$5.9M Buy
+66,100
New +$5.82M 0.01% 818

Other funds holding BSX

PEAK6's BSX Position: Q2 2026 in Review

PEAK6 increased its Boston Scientific (BSX) stake by 2,461% in Q2 2026, buying an estimated $35.7M and bringing the position to 683,808 shares worth $29.2M. The position accounts for 0.06% of the portfolio, ranked #258.

PEAK6 first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • PEAK6 held 683,808 shares of Boston Scientific worth $29.2M as of Q2 2026.
  • PEAK6 bought 657,108 Boston Scientific shares in Q2 2026, an estimated $35.7M.
  • Boston Scientific made up 0.06% of PEAK6's portfolio in Q2 2026, its #258 holding.
  • PEAK6 first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.